ClinicalTrials.Veeva

Menu

Validation of French Version of LCADL and Dyspnea-12

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Copd

Study type

Observational

Funder types

Other

Identifiers

NCT02555202
LCADL (RB 15.037)

Details and patient eligibility

About

The main objective of this study is to develop and to validate a French version of the London Chest Activity of Daily Living (LCADL) and the Dyspnea 12 and to determine the reliability of this version for the evaluation of the dyspnea in the Activity of Daily Living in COPD patients (stages severe and very severe).

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COPD with FEV1< 50% of predictive value

Exclusion criteria

  • FEV1> 50% of predictive value
  • Patients with an exacerbation of COPD in the previous 30 days the inclusion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems